SIG: Cell and Gene Therapy

 View Only
  • 1.  CGT SIG March meeting summary

    Posted 04-03-2023 13:52

    All, 

    Happy Monday!  We had a fruitful discussion at our monthly meeting on March 25.  Please see the summary of the discussion below. 

    1. Update on the ISPE endorsed manuscript. 
      • Karin de Haart is leading this effort.
      • The first draft is populated but a few sections need to have finetuning.  
      • The final manuscript needs to submit the ISPE publication committee by the end of June.
      • Reviewers with a fresh pair of eyes are needed for the manuscript (Katie, Milene and Hojin volunteered)
    1. CGT SIG promotion video
      • ISPE membership committee reached out to our SIG to produce a promotion video.  We are going to take the challenge!
      • Katie Miller will lead this effort and will send a message to the CGT SIG members and call out all artists 😉   
    1. ISPE webinars
      • We discussed possibility to have a CGT SIG sponsored webinar at the end of this year or the beginning of next year.  
      • Topics for the webinar are open to members' suggestion. 

            4.  Jamie Geier will give a talk on Future Innovation and Outlook for the Field of Pharmacoepidemiology at ICPE mid-year meeting in Reykjavik.  She will reach out to CGT SIG members for input on her presentation related to CGT.

    Kind regards,

    Kui



    ------------------------------
    Kui Huang PhD
    Pfizer Inc
    New York NY
    +1 (212) 733-1009
    ------------------------------


  • 2.  RE: CGT SIG March meeting summary

    Posted 04-04-2023 08:12

    Thank you, Kui.

    Dear All,

    At the ICPE midyear meeting, I am part of a session entitled "Future Innovation and Outlook for the Field of Pharmacoepidemiology".  Please let me know what you think is critical to mention regarding CGTs.  I want to ensure that the SIG's voice is represented.  Thank you!

    Best,
    Jamie



    ------------------------------
    Jamie Geier PhD
    Novartis Pharma AG
    East Hanover NJ
    +1 (862) 217-9299
    ------------------------------